Balance Labs, Inc.
BLNC
$0.183
-$0.0095-4.94%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 250.37% | 207.89% | 246.62% | 233.58% | 128.81% |
| Gross Profit | -250.37% | -207.89% | -246.62% | -233.58% | -134.53% |
| SG&A Expenses | 283.52% | 91.19% | -58.06% | -11.50% | -115.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,354.55% | 142.61% | 40.53% | 80.99% | -93.22% |
| Operating Income | -1,354.55% | -142.61% | -40.53% | -80.99% | 77.89% |
| Income Before Tax | 8.62% | -180.64% | -4.03% | -33.91% | 34.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.62% | -180.64% | -4.03% | -33.91% | 34.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.62% | -180.64% | -4.03% | -33.91% | 34.42% |
| EBIT | -1,354.55% | -142.61% | -40.53% | -80.99% | 77.89% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 8.47% | -178.13% | -2.22% | -35.00% | 35.16% |
| Normalized Basic EPS | -105.88% | -55.56% | -17.86% | -29.63% | 34.62% |
| EPS Diluted | 34.94% | -178.13% | -2.22% | -35.00% | 38.97% |
| Normalized Diluted EPS | -105.88% | -55.56% | -17.86% | -29.63% | 34.62% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |